wikitox:2.1.6.1.1_calcium_channel_blockers_education_links
Differences
This shows you the differences between two versions of the page.
| — |
wikitox:2.1.6.1.1_calcium_channel_blockers_education_links [2018/09/01 09:00] (current) |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | ====== Calcium Channel Blockers Education Links ====== | ||
| + | |||
| + | |**File Name** |**File Type** |**Audience** |**Previous Use** |**Year Created** |**Country of Origin** |**Associated Files** |**Submitted by** | | ||
| + | |{{:wikitox:calcium_channel_blockers_acem_2003.ppt|Calcium channel blockers ACEM 2003.ppt}} [41 KB]|PPT| | |2003| | |Ian Whyte| | ||
| + | |{{:wikitox:ccb_cases.ppt|CCB_cases.ppt}} [177 KB]|PPT| | |2003| | |Ian Whyte| | ||
| + | |{{:wikitox:cardiac_contractility.ppt|Cardiac contractility.ppt}} [2.7 MB]|PPT| |NewYork PCC|2006|USA| |Dapo Odujebe| | ||
| + | |{{:wikitox:sevilla_insulin_3.pdf|Sevilla Insulin 3.pdf}} [3.9 MB]|PDF of a PPT| |EEAPCCT 2008|2008|Belgium| |Phillipe Hanston| | ||
| + | |{{:wikitox:ccb_new_york.ppt|CCB New York.ppt}} [849 KB]|PPT| | | | | |Rama Rao| | ||
| + | | | | | | | | | | | ||
| + | |||
| + | ===== ADDITIONAL REFERENCE ===== | ||
| + | |||
| + | Brassard E, Archambault P, Lacombe G, St-Onge M. Barriers and Facilitators of Intensivists' Adherence to Hyperinsulinemia-Euglycemia Therapy in the Treatment of Calcium Channel Blocker Poisoning. //J Med Toxicol// 2018 doi: 10.1007/s13181-018-0676-2 [[https://www.ncbi.nlm.nih.gov/pubmed/30047044|PMID 30047044]] | ||
| + | |||
| + | \\ | ||
| + | |||
/home/wikitoxo/public_html/data/pages/wikitox/2.1.6.1.1_calcium_channel_blockers_education_links.txt ยท Last modified: 2018/09/01 09:00 (external edit)
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Noncommercial-Share Alike 4.0 International
